MCMCB Pro
J3130

J3130Injection, testosterone enanthate, up to 200 mg

HCPCSTerminatedBETOS O1E

J3130 is a HCPCS Level II code for injection, testosterone enanthate, up to 200 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2014 and is not valid on new claims.

This code has been terminated

CMS terminated J3130 on December 31, 2014. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J3130

Long descriptor
Injection, testosterone enanthate, up to 200 mg

The official wording. This is what the code means.

Short descriptor
Testosterone enanthate inj

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 1982

When CMS introduced the code.

Terminated
December 31, 2014

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J3130

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J3130 is not quite right, the correct code is very often within a few positions of it.

  • J3090Injection, tedizolid phosphate, 1 mg
  • J3095Injection, telavancin, 10 mg
  • J3101Injection, tenecteplase, 1 mg
  • J3105Injection, terbutaline sulfate, up to 1 mg
  • J3110Injection, teriparatide, 10 mcg
  • J3111Injection, romosozumab-aqqg, 1 mg
  • J3120Injection, testosterone enanthate, up to 100 mgterminated
  • J3121Injection, testosterone enanthate, 1 mg
  • J3140Injection, testosterone suspension, up to 50 mgterminated
  • J3145Injection, testosterone undecanoate, 1 mg
  • J3150Injection, testosterone propionate, up to 100 mgterminated
  • J3230Injection, chlorpromazine hcl, up to 50 mg
  • J3240Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
  • J3241Injection, teprotumumab-trbw, 10 mg
  • J3243Injection, tigecycline, 1 mg
  • J3244Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg

Questions about J3130

What is HCPCS code J3130?

J3130 is a HCPCS Level II code for injection, testosterone enanthate, up to 200 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J3130?

The CMS HCPCS file marks J3130 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

Is J3130 still valid?

No. J3130 was terminated on December 31, 2014 and should not be used on new claims.

HCPCS Level II2026Q3-Jul· effective July 1, 2026